FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for determination of right ventricle diastolic dysfunction. In patients with no previous liver disease, polyhepato-graphic examination of portohepatic hemodynamics is performed. If observing persistent signs of disturbed hepatic outflow characterized by plate-like form of rheographic curve in hepatic region, recording with respiratory retention on the half-breath and negative result of the breath holding test at deep inspiration, diastolic dysfunction of the right ventricle is determined.
EFFECT: method provides higher sensitivity and accuracy of investigation, its cost reduction as a result of enlarging contingent of examined patients due to patients with emphysema adjacent to the heart of lung areas, as well as narrowing the intercostal space, due to use of significantly cheaper equipment.
1 cl, 5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INVASIVE DIAGNOSIS OF LEFT VENTRICULAR PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC CONNECTIVE TISSUE DISEASES WITH NORMAL PULMONARY ARTERY OCCLUSIVE PRESSURE | 2019 |
|
RU2720823C1 |
METHOD FOR PREDICTING DEVELOPMENT OF PULMONARY HYPERTENSION AT THE END OF SUBACUTE MYOCARDIAL INFARCTION IN MEN YOUNGER THAN 60 YEARS OLD | 2020 |
|
RU2735996C1 |
METHOD OF SELECTING PATIENTS WITH DECOMPENSATED ISCHEMIC CHRONIC CARDIAC FAILURE TO PERFORM ENDOMYOCARDIAL BIOPSY | 2019 |
|
RU2728095C1 |
METHOD FOR ASSESSING LIKELIHOOD OF DAMAGE TO RIGHT HEART DURING HYPOXIC PULMONARY VASOCONSTRICTION IN PATIENTS WHO HAVE COVID-19 ASSOCIATED PNEUMONIA | 2023 |
|
RU2813269C1 |
METHOD OF PREDICTING RISK OF DEVELOPING FUNCTIONAL CLASS III CHRONIC HEART FAILURE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2807272C1 |
METHOD FOR ASSESSING LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN SMOKERS WITH EARLY STAGES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF LIGHT DEGREE AND ARTERIAL HYPERTENSION OF I STAGE | 2020 |
|
RU2743245C1 |
METHOD FOR PERSONALIZING THE APPROACH TO INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION | 2022 |
|
RU2791135C1 |
METHOD OF DIFFERENTIAL DIAGNOSTIC OF ACUTE PULMONARY THROMBOEMBOLISM AND CHRONIC POSTEMBOLIC PULMONARY HYPERTENSION | 2014 |
|
RU2545927C1 |
METHOD FOR ASSESSING CLINICAL SIGNIFICANCE OF ATRIAL FIBRILLATION IN DETERMINING INDICATION FOR ATRIAL FIBRILLATION INTERVENTIONAL TREATMENT | 2022 |
|
RU2791191C1 |
METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2018 |
|
RU2716479C1 |
Authors
Dates
2019-07-30—Published
2018-11-07—Filed